End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,81,000 KRW | +0.77% | -2.62% | +2.76% |
25/04 | Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe | MT |
25/04 | Samsung Biologics Posts Higher Q1 Profit, Sales | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.76% | 40.25B | |
-3.79% | 87.06B | |
-17.49% | 31.09B | |
+54.94% | 24.74B | |
-13.13% | 15.91B | |
-9.12% | 11.96B | |
-15.45% | 11.92B | |
-42.56% | 11.61B | |
+6.07% | 8.73B | |
-4.33% | 8.69B |
- Stock Market
- Equities
- A207940 Stock
- News Samsung Biologics Co.,Ltd.
- Market Chatter: Samsung Biologics' Net Profit Rises 19% in 2020 on Higher Sales and Better Factory Usage; Shares Soar 6%